Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint Dive into the research topics of 'Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes'. Together they form a unique fingerprint.

Medicine & Life Sciences